Dattwyler R J, Halperin J J, Volkman D J, Luft B J
Department of Internal Medicine, School of Medicine, State University of New York, Stony Brook.
Lancet. 1988 May 28;1(8596):1191-4. doi: 10.1016/s0140-6736(88)92011-9.
23 patients with clinically active late Lyme disease were randomly assigned to intravenous treatment with either penicillin or ceftriaxone. Of the 10 treated with penicillin, 5 were judged treatment failures; of the 13 who received ceftriaxone, only 1 did not respond. An additional 31 patients were subsequently treated with ceftriaxone 4 g/day (n = 17) or 2 g/day (n = 14); success rates in both groups were comparable to those in the cohort randomised to ceftriaxone. Patients unresponsive to ceftriaxone were more likely to have received corticosteroid treatment.